Skip to content

Phase 1 Study of IMC-P115C in Advanced PRAME Positive Cancers

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-509767-25-00
Acronym
IMC-P115C-1005
Enrollment
410
Registered
2024-09-12
Start date
2024-11-07
Completion date
Unknown
Last updated
2025-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced PRAME Positive Cancers

Interventions

None listed

Sponsors

Immunocore Limited
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

France, Italy, Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026